Skip to main content

Advertisement

SpringerLink
Log in

Clinical significance of IGF1R gene expression in patients with Stage II/III gastric cancer who receive curative surgery and adjuvant chemotherapy with S-1

  • Original Article – Cancer Research
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Curative resection and adjuvant chemotherapy is the standard treatment for Stage II/III gastric cancer, and S-1 is widely used for adjuvant chemotherapy. The type 1 insulin-like growth factor receptor (IGF1R) is involved in cell proliferation and prevention of apoptosis in many tumors. We evaluated the relative expression of the IGF1R gene to determine whether such expression correlates with outcomes in patients with Stage II/III gastric cancer.

Methods

We measured the expression levels of the IGF1R gene in specimens of cancer and adjacent normal mucosa obtained from 134 patients with Stage II/III gastric cancer who received curative resection and adjuvant chemotherapy with S-1. We then evaluated whether the IGF1R gene expression levels correlate with clinicopathological characteristics and outcomes.

Results

IGF1R mRNA expression levels tended to be higher in cancer tissue than in the normal adjacent mucosa (P = 0.078). Multivariate analysis showed that high IGF1R gene expression was a significant independent predictor of poor survival in Stage II/III gastric cancer after curative resection and adjuvant chemotherapy with S-1 (HR 3.681, P = 0.007). The overall survival rate was significantly lower in patients with high IGF1R gene expression than in those with low expression (P = 0.012).

Conclusions

IGF1R overexpression is considered a useful independent predictor of outcomes in Stage II/III gastric cancer after curative resection and adjuvant chemotherapy with S-1.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Adachi Y et al (2009) Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin. Carcinogenesis 30:1305–1313. doi:10.1093/carcin/bgp134

    Article  PubMed  CAS  Google Scholar 

  • Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15:6541–6551

    PubMed  PubMed Central  CAS  Google Scholar 

  • Belham C, Wu S, Avruch J (1999) Intracellular signalling: PDK1—a kinase at the hub of things. Curr Biol 9:R93–R96

    Article  PubMed  CAS  Google Scholar 

  • Blakesley VA, Stannard BS, Kalebic T, Helman LJ, LeRoith D (1997) Role of the IGF-I receptor in mutagenesis and tumor promotion. J Endocrinol 152:339–344

    Article  PubMed  CAS  Google Scholar 

  • Brodt P, Samani A, Navab R (2000) Inhibition of the type I insulin-like growth factor receptor expression and signaling: novel strategies for antimetastatic therapy. Biochem Pharmacol 60:1101–1107

    Article  PubMed  CAS  Google Scholar 

  • Dallas NA et al (2009) Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res 69:1951–1957. doi:10.1158/0008-5472.CAN-08-2023

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278:687–689

    Article  PubMed  Google Scholar 

  • Downward J (1998) Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10:262–267

    Article  PubMed  CAS  Google Scholar 

  • Dudek H et al (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275:661–665

    Article  PubMed  CAS  Google Scholar 

  • Ferlay J et al (2014) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. doi:10.1002/ijc.29210

    PubMed  Google Scholar 

  • Furstenberger G, Senn HJ (2002) Insulin-like growth factors and cancer. Lancet Oncol 3:298–302

    Article  PubMed  CAS  Google Scholar 

  • Galamb O, Sipos F, Molnar B, Szoke D, Spisak S, Tulassay Z (2007) Evaluation of malignant and benign gastric biopsy specimens by mRNA expression profile and multivariate statistical methods. Cytometry B Clin Cytom 72:299–309. doi:10.1002/cyto.b.20189

    Article  PubMed  CAS  Google Scholar 

  • Ge J, Chen Z, Wu S, Chen J, Li X, Li J, Yin J (2009) Expression levels of insulin-like growth factor-1 and multidrug resistance-associated protein-1 indicate poor prognosis in patients with gastric cancer. Digestion 80:148–158. doi:10.1159/000226089

    Article  PubMed  CAS  Google Scholar 

  • Hellawell GO, Turner GD, Davies DR, Poulsom R, Brewster SF, Macaulay VM (2002) Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease. Cancer Res 62:2942–2950

    PubMed  CAS  Google Scholar 

  • Hilmi C, Larribere L, Giuliano S, Bille K, Ortonne JP, Ballotti R, Bertolotto C (2008) IGF1 promotes resistance to apoptosis in melanoma cells through an increased expression of BCL2, BCL-X(L), and survivin. J Invest Dermatol 128:1499–1505. doi:10.1038/sj.jid.5701185

    Article  PubMed  CAS  Google Scholar 

  • Hopkins A, Crowe PJ, Yang JL (2010) Effect of type 1 insulin-like growth factor receptor targeted therapy on chemotherapy in human cancer and the mechanisms involved. J Cancer Res Clin Oncol 136:639–650. doi:10.1007/s00432-010-0792-0

    Article  PubMed  CAS  Google Scholar 

  • Imsumran A et al (2007) Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinoma. Carcinogenesis 28:947–956. doi:10.1093/carcin/bgl247

    Article  PubMed  CAS  Google Scholar 

  • Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48:452–458. doi:10.1038/bmt.2012.244

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Kharbanda S et al (1997) Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. Proc Natl Acad Sci USA 94:6939–6942

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Li H et al (2011) Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45. Cancer 117:3135–3147. doi:10.1002/cncr.25893

    Article  PubMed  CAS  Google Scholar 

  • Long L, Rubin R, Baserga R, Brodt P (1995) Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor. Cancer Res 55:1006–1009

    PubMed  CAS  Google Scholar 

  • Long L, Rubin R, Brodt P (1998) Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor. Exp Cell Res 238:116–121. doi:10.1006/excr.1997.3814

    Article  PubMed  CAS  Google Scholar 

  • Ludovini V et al (2009) High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients. Ann Oncol 20:842–849. doi:10.1093/annonc/mdn727

    Article  PubMed  CAS  Google Scholar 

  • Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J (2000) High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. J Clin Endocrinol Metab 85:3653–3660. doi:10.1210/jcem.85.10.6906

    PubMed  CAS  Google Scholar 

  • Mazumdar M, Smith A, Bacik J (2003) Methods for categorizing a prognostic variable in a multivariable setting. Stat Med 22:559–571. doi:10.1002/sim.1333

    Article  PubMed  Google Scholar 

  • Min KW (2010) Gastrointestinal stromal tumor: an ultrastructural investigation on regional differences with considerations on their histogenesis. Ultrastruct Pathol 34:174–188. doi:10.3109/01913121003689075

    Article  PubMed  Google Scholar 

  • Pavelic K, Kolak T, Kapitanovic S, Radosevic S, Spaventi S, Kruslin B, Pavelic J (2003) Gastric cancer: the role of insulin-like growth factor 2 (IGF 2) and its receptors (IGF 1R and M6-P/IGF 2R). J Pathol 201:430–438. doi:10.1002/path.1465

    Article  PubMed  CAS  Google Scholar 

  • Sakuramoto S et al (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810–1820. doi:10.1056/NEJMoa072252

    Article  PubMed  CAS  Google Scholar 

  • Sasako M et al (2011) Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol 29:4387–4393. doi:10.1200/JCO.2011.36.5908

    Article  PubMed  CAS  Google Scholar 

  • Shiraishi T, Mori M, Yamagata M, Haraguchi M, Ueo H, Sugimachi K (1998) Expression of insulin-like growth factor 2 mRNA in human gastric cancer. Int J Oncol 13:519–523

    PubMed  CAS  Google Scholar 

  • Steller MA, Delgado CH, Bartels CJ, Woodworth CD, Zou Z (1996) Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells. Cancer Res 56:1761–1765

    PubMed  CAS  Google Scholar 

  • Valsecchi ME et al (2012) Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma. Cancer 118:3484–3493. doi:10.1002/cncr.26661

    Article  PubMed  CAS  Google Scholar 

  • Weber MM, Fottner C, Liu SB, Jung MC, Engelhardt D, Baretton GB (2002) Overexpression of the insulin-like growth factor I receptor in human colon carcinomas. Cancer 95:2086–2095. doi:10.1002/cncr.10945

    Article  PubMed  CAS  Google Scholar 

  • Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87:619–628

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan

    Koji Numata, Takashi Oshima, Kazue Yoshihara, Takanobu Yamada, Yasushi Rino, Toshio Imada & Munetaka Masuda

  2. Department of Biostatistics, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan

    Kentaro Sakamaki

  3. Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama, 241-8515, Japan

    Toru Aoyama, Tsutomu Sato, Haruhiko Cho, Manabu Shiozawa, Takaki Yoshikawa & Makoto Akaike

  4. Department of Gastroenterological Surgery, Yokohama City University Medical Center, 4-57 Urafune, Minami-ku, Yokohama, 232-0024, Japan

    Tsutomu Hayashi & Chikara Kunisaki

Authors
  1. Koji Numata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takashi Oshima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kentaro Sakamaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazue Yoshihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Toru Aoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tsutomu Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Takanobu Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tsutomu Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Haruhiko Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Manabu Shiozawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Takaki Yoshikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yasushi Rino
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Chikara Kunisaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Makoto Akaike
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Toshio Imada
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Munetaka Masuda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takashi Oshima.

Ethics declarations

Conflict of interest

None.

Ethical approval

All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Numata, K., Oshima, T., Sakamaki, K. et al. Clinical significance of IGF1R gene expression in patients with Stage II/III gastric cancer who receive curative surgery and adjuvant chemotherapy with S-1. J Cancer Res Clin Oncol 142, 415–422 (2016). https://doi.org/10.1007/s00432-015-2039-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-015-2039-6

Keywords

Search

Navigation